Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

LIPO-SEP CHOLESTEROL AUDIT SYSTEM

K-Number: K812318 · 1981-09-01

ApplicantIsolab, Inc.
Decision Date1981-09-01
Product Code
DecisionSubstantially Equivalent

Device Summary

LIPO-SEP CHOLESTEROL AUDIT SYSTEM is the device name listed in this FDA 510(k) record. The listed applicant is Isolab, Inc.. It received FDA 510(k) clearance on 1981-09-01 under 510(k) number K812318. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the LIPO-SEP CHOLESTEROL AUDIT SYSTEM?

LIPO-SEP CHOLESTEROL AUDIT SYSTEM is a medical device that received FDA 510(k) clearance on 1981-09-01. The listed applicant is Isolab, Inc.. The 510(k) number is K812318.

When did LIPO-SEP CHOLESTEROL AUDIT SYSTEM receive FDA 510(k) clearance?

LIPO-SEP CHOLESTEROL AUDIT SYSTEM received FDA 510(k) clearance on 1981-09-01, under 510(k) number K812318.

Who is the listed applicant for LIPO-SEP CHOLESTEROL AUDIT SYSTEM?

The FDA 510(k) record lists Isolab, Inc. as the applicant. This does not by itself establish the device manufacturer.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Other records listing Isolab, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

View all 44 devices →

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑